Intrinsic Value
Newron Pharmaceuticals SpA (NP5.DE)
7.2 €
+0.30 (+4.35%)
| Enterprise Value | -575.27 |
|---|---|
| Net Debt | 42.10 |
| Equity Value | -617.37 |
| Shares Outstanding | 17.84 |
| Equity Value Per Share | -34.60 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt